Abstract
Parenteral immunization of transgenic mouse models of Alzheimer disease (AD) with synthetic amyloid beta-peptide (Abeta) prevented or reduced Abeta deposits and attenuated their memory and learning deficits. A clinical trial of immunization with synthetic Abeta, however, was halted due to brain inflammation, presumably induced by a toxic Abeta, T-cell- and/or Fc-mediated immune response. Another issue relating to such immunizations is that some AD patients may not be able to raise an adequate immune response to Abeta vaccination due to immunological tolerance or age-associated decline. Because peripheral administration of antibodies against Abeta also induced clearance of amyloid plaques in the model mice, injection of humanized Abeta antibodies has been proposed as a possible therapy for AD. By screening a human single-chain antibody (scFv) library for Abeta immunoreactivity, we have isolated a scFv that specifically reacts with oligomeric Abeta as well as amyloid plaques in the brain. The scFv inhibited Abeta amyloid fibril formation and Abeta-mediated cytotoxicity in vitro. We have tested the efficacy of the human scFv in a mouse model of AD (Tg2576 mice). Relative to control mice, injections of the scFv into the brain of Tg...Continue Reading
References
Oct 4, 1996·Science·K HsiaoG Cole
Feb 2, 2002·Nature·Erika Check
Apr 5, 2002·Nature·Dominic M WalshDennis J Selkoe
Jun 12, 2002·The Journal of Biological Chemistry·Karie N DahlgrenMary Jo LaDu
Nov 27, 2002·Vaccine·Edward T SpoonerCynthia A Lemere
Jan 25, 2003·The European Journal of Neuroscience·Debby Van DamPeter P De Deyn
Jul 9, 2003·Neurology·J-M OrgogozoC Hock
Jun 2, 2004·Biochemistry·Ruitian LiuMichael R Sierks
Mar 16, 2005·The Journal of Cell Biology·Paolo PaganettiMaurizio Molinari
Citations
Sep 5, 2012·Journal of Molecular Neuroscience : MN·Junling YangKen-ichiro Fukuchi
Nov 23, 2012·ACS Chemical Neuroscience·Pauline T VelascoWilliam L Klein
Jul 30, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Kelly L SudolWilliam J Bowers
Jun 17, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Deborah A RyanWilliam J Bowers
Nov 6, 2009·The Journal of Biological Chemistry·Sharad P AdekarBrian O'Nuallain
Jun 15, 2013·Protein Engineering, Design & Selection : PEDS·R M NisbetS D Nuttall
Apr 13, 2011·PloS One·Susann CattepoelRoger M Nitsch
Nov 8, 2012·PloS One·Shi-gao YangRui-tian Liu
Nov 14, 2007·Expert Review of Neurotherapeutics·Cheryl A Hawkes, Joanne McLaurin
Nov 24, 2007·Expert Opinion on Biological Therapy·Brian SpencerEliezer Masliah
Jan 26, 2011·Expert Opinion on Biological Therapy·Refik PulMartin Stangel
Nov 19, 2013·The Journal of Pharmacy and Pharmacology·Brígida R PinhoPaula B Andrade
Aug 9, 2015·Human Molecular Genetics·Pedro Fernandez-FunezDiego E Rincon-Limas
Oct 22, 2014·Molecular Neurobiology·Yuan ZhangYing-Jiu Zhang
Jun 25, 2014·Free Radical Biology & Medicine·Wei-wei ZhouRui-tian Liu
Apr 20, 2011·The Biochemical Journal·Marta Marín-ArganySandra Villegas
Aug 9, 2013·MAbs·Geovanny Rivera-HernándezSandra Villegas
Apr 16, 2014·Molecular Neurobiology·Jinghong KouKen-Ichiro Fukuchi
Jan 19, 2007·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Clifford R JackMichael Garwood
Jan 27, 2020·Neurobiology of Disease·Senthilkumar KrishnaswamyEinar M Sigurdsson